Registro:

Referencias:

• Adams, A., Crystal structures of acridines complexed with nucleic acids (2002) Curr. Med. Chem., 9, pp. 1667-1675
• Andrei, G., De Clercq, E., Molecular approaches for the treatment of hemorrhagic fever virus infections (1993) Antiviral Res., 22, pp. 45-75
• Artuso, M.C., Ellenberg, P.C., Scolaro, L.A., Damonte, E.B., García, C.C., Inhibition of Junín virus replication by small interfering RNAs (2009) Antiviral Res., 84, pp. 31-37
• Bastow, K.F., New acridone inhibitors of human herpes virus replication (2004) Curr. Drug Targets Infect. Disord., 4, pp. 323-330
• Belmont, P., Bosson, J., Godet, T., Tiano, M., Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now? (2007) Anticancer Agents Med. Chem., 7, pp. 139-169
• Briese, T., Paweska, J.T., McMullan, L.K., Hutchison, S.K., Street, C., Palacios, G., Khristova, M.L., Lipkin, W.I., Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa (2009) PLoS Pathog., 5, pp. e1000455
• Damonte, E.B., Coto, C.E., Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy (2002) Adv. Virus Res., 58, pp. 125-155
• Delgado, S., Erickson, B.R., Agudo, R., Blair, P.J., Vallejo, E., Albariño, C.G., Vargas, J., Nichol, S.T., Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia (2008) PLoS Pathog., 4, pp. e1000047
• Ellenberg, P., Linero, F.N., Scolaro, L.A., Superinfection exclusion in BHK-21 cells persistently infected with Junin virus (2007) J. Gen. Virol., 88, pp. 2730-2739
• Enría, D.A., Briggiler, A.M., Levis, S., Vallejos, D., Maiztegui, J.I., Canonico, P.G., Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever (1987) Antiviral Res., 7, pp. 353-359
• Enría, D.A., Maiztegui, J.I., Antiviral treatment of Argentine hemorrhagic fever (1994) Antiviral Res., 23, pp. 23-31
• Eriksson, B., Helgstrand, E., Johansson, N.G., Larsson, A., Misiorny, A., Norén, J.O., Philipson, L., öberg, B., Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate (1977) Antimicrob. Agents Chemother., 11, pp. 946-951
• Fascio, M.L., D'Accorso, N.B., Pellón, R.F., Docampo, M.L., Synthesis of novel carbohydrate acridinone derivatives with potential biological activities by using 1,3-dipolar cyclo addition (2007) Synth. Commun., 37, pp. 4209-4217
• Fischer, S.A., Graham, M.B., Kuehnert, M.J., Kotton, C.N., Srinivasan, A., Marty, F.M., Comer, J.A., Zaki, S.R., LCMV in transplant recipients investigation team, transmission of lymphocytic choriomeningitis virus by organ transplantation (2006) N. Engl. J. Med., 354, pp. 2235-2249
• Fisher-Hoch, S.P., Ghorie, S., Parker, L., Huggins, J., Unexpected adverse reactions during a clinical trial in rural West Africa (1992) Antiviral Res., 19, pp. 139-147
• Fujiwara, M., Okamoto, M., Okamoto, M., Watanabe, M., Machida, H., Shigeta, S., Konno, K., Baba, M., Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells (1999) Antiviral Res., 43, pp. 189-199
• García, C.C., Sepúlveda, C.S., Damonte, E.B., Novel therapeutic targets for arenavirus hemorrhagic fevers (2011) Future Virol., 6, pp. 27-44
• Goswami, B.B., Borek, E., Sharma, O.K., Fujitaki, J., Smith, R.A., The broad spectrum antiviral agent ribavirin inhibits capping of mRNA (1979) Biochem. Biophys. Res. Commun., 89, pp. 830-836
• Graci, J.D., Cameron, C.E., Quasispecies, error catastrophe, and the antiviral activity of ribavirin (2002) Virology, 298, pp. 175-180
• Hedge, R., Thimmaiah, P., Yerigeri, M.C., Krishnegowda, G., Thimmaiah, K.N., Houghton, P.J., Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells (2004) Eur. J. Med. Chem., 39, pp. 161-177
• Jamieson, D.J., Kourtis, A.P., Bell, M., Rasmussen, S.A., Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? (2006) Am. J. Obstet. Gynecol., 194, pp. 1532-1536
• Kelly, J.X., Smilkstein, M.J., Brun, R., Wittlin, S., Cooper, R.A., Lane, K.D., Janowsky, A., Riscoe, M.K., Discovery of dual function acridones as a new antimalarial chemotype (2009) Nature, 459, pp. 270-273
• Kitchin, J.E., Pomeranz, M.K., Pak, G., Washenik, K., Shupack, J.L., Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses (1997) J. Am. Acad. Dermatol., 37, pp. 445-449
• Leyssen, P., Balzarini, J., De Clercq, E., Neyts, J., The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase (2005) J. Virol., 79, pp. 1943-1947
• Manfroni, G., Paeshuyse, J., Massari, S., Zanoli, S., Gatto, B., Maga, G., Tabarrini, O., Neyts, J., Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor (2009) J. Med. Chem., 52, pp. 3354-3365
• McCormick, J.B., Fisher-Hoch, S.P., Lassa fever (2002) Curr. Top. Microbiol. Immunol., 262, pp. 75-109
• McCormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., Elliott, L.H., Belmont-Williams, R., Lassa fever. Effective therapy with ribavirin (1986) N. Engl. J. Med., 314, pp. 20-26
• McKee, K.T., Huggins, J.W., Trahan, C.J., Mahlandt, B.G., Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever (1988) Antimicrob. Agents Chemother., 32, pp. 1304-1309
• Mersich, S.E., Damonte, E.B., Coto, C.E., Induction of RNA polymerase II activity in Junin virus-infected cells (1981) Intervirology, 16, pp. 123-127
• Moreno, H., Gallego, I., Sevilla, N., de la Torre, J.C., Domingo, E., Martín, V., Ribavirin can be mutagenic for arenaviruses (2011) J. Virol., 85, pp. 7246-7255
• ölschläger, S., Neyts, J., Günther, S., Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus (2011) Antiviral Res., 91, pp. 89-93
• Peters, C.J., Human infection with arenaviruses in the Americas (2002) Curr. Top. Microbiol. Immunol., 262, pp. 65-74
• Rankin, J.T., Eppes, S.B., Antczak, J.B., Joklik, W.K., Studies on the mechanism of the antiviral activity of ribavirin against reovirus (1989) Virology, 168, pp. 147-158
• Rice, W.G., Baker, D.C., Schaeffer, C.A., Graham, L., Bu, M., Terpening, S., Clanton, D., Turpin, J.A., Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins (1997) Antimicrob. Agents Chemother., 41, pp. 419-426
• Ruiz-Jarabo, C.M., Ly, C., Domingo, E., de la Torre, J.C., Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) (2003) Virology, 308, pp. 37-47
• Sanchez, A., Pifat, D.Y., Kenyon, R.H., Peters, C.J., McCormick, J.B., Kiley, M.P., Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses (1989) J. Gen. Virol., 70, pp. 1125-1132
• Sepúlveda, C.S., Fascio, M.L., Mazzucco, M.B., Docampo Palacios, M.L., Pellón, R.F., García, C.C., D'Accorso, N.B., Damonte, E.B., Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses (2008) Antivir. Chem. Chemother., 19, pp. 41-47
• Singh, P., Kaur, J., Yadav, B., Komath, S.S., Design, synthesis and evaluations of acridone derivatives using Candida albicans-search for MDR modulators led to the identification of an anti-candidiasis agent (2009) Bioorg. Med. Chem., 17, pp. 3973-3979
• Sintchak, M.D., Nimmesgern, E., The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors (2000) Immunopharmacology, 47, pp. 163-184
• Stankiewicz-Drogon, A., Dorner, B., Erker, T., Boguszewska-Chachulska, A.M., Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication (2010) J. Med. Chem., 53, pp. 3117-3126
• Stránská, R., van Loon, A.M., Polman, M., Schuurman, R., Application of real-time PCR for determination of antiviral drug susceptibility of herpes simplex virus (2002) Antimicrob. Agents Chemother., 46, pp. 2943-2947
• Streeter, D.G., Witkowski, J.T., Khare, G.P., Sidwell, R.W., Bauer, R.J., Robins, R.K., Simon, L.N., Mechanism of action of 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent (1973) Proc. Natl. Acad. Sci. USA, 70, pp. 1174-1178
• Tabarrini, O., Manfroni, G., Fravolini, A., Cecchetti, V., Sabatini, S., De Clercq, E., Rozenski, J., Neyts, J., Synthesis and anti-BVDV activity of acridones as new potential antiviral agents (2006) J. Med. Chem., 49, pp. 2621-2627
• Talarico, L.B., Damonte, E.B., Interference in dengue virus adsorption and uncoating by carrageenans (2007) Virology, 363, pp. 473-485
• Toltzis, P., O'Connell, K., Patterson, J.L., Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription (1988) Antimicrob. Agents Chemother., 32, pp. 492-497
• Vispé, S., Vandenberghe, I., Robin, M., Annereau, J.P., Créancier, L., Pique, V., Galy, J.P., Bailly, C., Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome (2007) Biochem. Pharmacol., 73, pp. 1863-1872
• Watterson, S.H., Chen, P., Zhao, Y., Gu, H.H., Murali Dhar, T.G., Xiao, Z., Ballentine, S.K., Iwanowicz, E.J., Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroxyacridine-3-carboxamide (BMS-566419) (2007) J. Med. Chem., 50, pp. 3730-3742
• Whitby, K., Pierson, T.C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R.W., Diamond, M.S., Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo (2005) J. Virol., 79, pp. 8698-8706
• Zarubaev, V.V., Slita, A.V., Krivitskaya, V.Z., Sirotkin, A.K., Kovalenko, A.L., Chatterjee, N.K., Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro (2003) Antiviral Res., 58, pp. 131-137

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------